These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 10421611

  • 21. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
    Yang TJ, Sai Y, Krausz KW, Gonzalez FJ, Gelboin HV.
    Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
    [Abstract] [Full Text] [Related]

  • 22. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH, Or PM.
    Phytomedicine; 2012 Mar 15; 19(5):457-63. PubMed ID: 22305191
    [Abstract] [Full Text] [Related]

  • 23. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M, Hofmann U, Klein K, Mürdter T, Schwab M, Zanger UM.
    Drug Metab Dispos; 2009 May 15; 37(5):1017-24. PubMed ID: 19204080
    [Abstract] [Full Text] [Related]

  • 24. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
    Lu P, Schrag ML, Slaughter DE, Raab CE, Shou M, Rodrigues AD.
    Drug Metab Dispos; 2003 Nov 15; 31(11):1352-60. PubMed ID: 14570767
    [Abstract] [Full Text] [Related]

  • 25. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT, Chang YW, Lan SJ, Chen CT, Hsu JT, Yeh TK.
    Life Sci; 2006 Nov 25; 79(26):2432-40. PubMed ID: 16978661
    [Abstract] [Full Text] [Related]

  • 26. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.
    Lee SH, Slattery JT.
    Drug Metab Dispos; 1997 Dec 25; 25(12):1354-8. PubMed ID: 9394024
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T.
    Br J Clin Pharmacol; 1995 Apr 25; 39(4):421-31. PubMed ID: 7640150
    [Abstract] [Full Text] [Related]

  • 30. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
    Peng WX, Wang LS, Li HD, Abd El-Aty AM, Chen GL, Zhou HH.
    Clin Chim Acta; 2003 Aug 25; 334(1-2):77-85. PubMed ID: 12867277
    [Abstract] [Full Text] [Related]

  • 31. Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.
    Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivistö KT.
    Drug Metab Dispos; 2000 Aug 25; 28(8):959-65. PubMed ID: 10901707
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
    Pan LP, Wijnant P, De Vriendt C, Rosseel MT, Belpaire FM.
    Br J Clin Pharmacol; 1997 Dec 25; 44(6):557-64. PubMed ID: 9431831
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
    Or PM, Lam FF, Kwan YW, Cho CH, Lau CP, Yu H, Lin G, Lau CB, Fung KP, Leung PC, Yeung JH.
    Phytomedicine; 2012 Apr 15; 19(6):535-44. PubMed ID: 22261394
    [Abstract] [Full Text] [Related]

  • 37. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
    Wang X, Cheung CM, Lee WY, Or PM, Yeung JH.
    Phytomedicine; 2010 Sep 15; 17(11):868-75. PubMed ID: 20638257
    [Abstract] [Full Text] [Related]

  • 38. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
    Venkatakrishnan K, von Moltke LL, Duan SX, Fleishaker JC, Shader RI, Greenblatt DJ.
    J Pharm Pharmacol; 1998 Mar 15; 50(3):265-74. PubMed ID: 9600717
    [Abstract] [Full Text] [Related]

  • 39. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M, Meunier V, Berger Y, Fabre G.
    J Pharmacol Exp Ther; 1996 Apr 15; 277(1):321-32. PubMed ID: 8613937
    [Abstract] [Full Text] [Related]

  • 40. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
    Yamamura Y, Koyama N, Umehara K.
    Xenobiotica; 2015 Apr 15; 45(4):353-60. PubMed ID: 25815637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.